DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Parikh A, Leach T, Wyant T et al.
Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study.
Inflammat Bowel Dis 2012;
18: 1470-1479
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.